|
Volumn 38, Issue 8, 2001, Pages 615-624
|
Effects of theophylline withdrawal in well-controlled asthmatics treated with inhaled corticosteroid
a,b b b b b b b b c |
Author keywords
Asthma; Eosinophil cationic protein (ECP); Step down; Theophylline
|
Indexed keywords
BECLOMETASONE DIPROPIONATE;
EOSINOPHIL CATIONIC PROTEIN;
THEOPHYLLINE;
ADULT;
ARTICLE;
ASTHMA;
BRONCHODILATATION;
CLINICAL ARTICLE;
DISEASE COURSE;
DISEASE EXACERBATION;
DRUG EFFECT;
DRUG WITHDRAWAL;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMAN;
MALE;
PEAK EXPIRATORY FLOW;
SPIROMETRY;
SYMPTOMATOLOGY;
VELOCITY;
VITAL CAPACITY;
ADULT;
AGED;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
BECLOMETHASONE;
BLOOD PROTEINS;
BRONCHODILATOR AGENTS;
DRUG THERAPY, COMBINATION;
EOSINOPHIL GRANULE PROTEINS;
EOSINOPHILS;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMANS;
MALE;
MIDDLE AGED;
RIBONUCLEASES;
SPIROMETRY;
SUBSTANCE WITHDRAWAL SYNDROME;
THEOPHYLLINE;
TIME FACTORS;
|
EID: 0035185238
PISSN: 02770903
EISSN: None
Source Type: Journal
DOI: 10.1081/JAS-100107539 Document Type: Article |
Times cited : (10)
|
References (15)
|